SUCHETA TELANG, MD
Medical Practice at Floyd St, Louisville, KY

License number
Kentucky 37099
Category
Medical Practice
Type
Pediatrics
License number
Kentucky 37099
Category
Medical Practice
Type
Neonatal-Perinatal Medicine
Address
Address
571 S Floyd St STE 342, Louisville, KY 40202
Phone
(502) 852-8470
(502) 588-0329
(502) 588-0326 (Fax)

Personal information

See more information about SUCHETA TELANG at radaris.com
Name
Address
Phone
Sucheta Telang
500 Jefferson St, Louisville, KY 40202
(502) 583-0127
Sucheta Telang
601 Floyd St, Louisville, KY 40202
(502) 583-0127

Organization information

See more information about SUCHETA TELANG at bizstanding.com

Sucheta Telang MD,MBBS,BS

571 S Floyd St, Louisville, KY 40202

Industry:
Pediatrician
Phone:
(502) 852-8470 (Phone)
Description:
There are 15 doctors at this site. Surgery is not performed at this site.
Sucheta Dinbandhu Telang

Professional information

Sucheta Telang Photo 1

Small-Molecule Choline Kinase Inhibitors As Anti-Cancer Therapeutics

US Patent:
2011025, Oct 20, 2011
Filed:
Dec 22, 2010
Appl. No.:
12/975631
Inventors:
Pooran Chand - Birmingham AL, US
Jason A. Chesney - Louisville KY, US
Brian F. Clem - Louisville KY, US
Gilles H. Tapolsky - Louisville KY, US
Sucheta Telang - Louisville KY, US
John O. Trent - Louisville KY, US
Assignee:
ADVANCED CANCER THERAPEUTICS, LLC - Louisville KY
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
A61K 31/506, C07D 417/12, C07D 401/12, C07D 401/04, C07D 403/12, A61P 35/00, A61K 31/427, A61K 31/4439, A61K 31/4709, A61K 31/428, A61K 31/454, C12N 9/99, C07D 249/12, A61K 31/4196
US Classification:
514275, 5482644, 548195, 5462724, 546167, 548163, 544331, 546210, 514383, 514371, 514341, 514314, 514367, 514326, 435184
Abstract:
Small molecule choline kinase inhibitors having the following formula:are provided herein. Also provided herein are pharmaceutical compositions containing Formula I compounds, together with methods of treating cancer, methods of inhibiting choline kinase enzymatic activity, and methods of treating tumors by administering an effective amount of a Formula I compound.


Sucheta Telang Photo 2

Small Molecule Choline Kinase Inhibitors, Screening Assays, And Methods For Treatment Of Neoplastic Disorders

US Patent:
2013001, Jan 10, 2013
Filed:
May 12, 2012
Appl. No.:
13/470274
Inventors:
Brian Clem - Louisville KY, US
Sucheta Telang - Louisville KY, US
John Trent - Louisville KY, US
Jason Chesney - Louisville KY, US
Pooran Chand - Birmingham AL, US
Gilles Tapolsky - Louisville KY, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
A61K 31/4196, A61K 31/216, G06F 19/16, C07C 69/736, C07C 69/157, A61P 35/00, A61K 31/222, C07D 249/12
US Classification:
514384, 514543, 514546, 514510, 5482644, 560 61, 560130, 703 11
Abstract:
Small molecule choline kinase inhibitors, pharmaceutical compositions thereof, and screening methods for identifying and evaluating choline kinase inhibitors are provided. Safe and effective methods for treating subjects suffering from a disorder or disease characterized by neoplastic cell proliferation employing the choline kinase inhibitors are also provided.


Sucheta Telang Photo 3

Small Molecule Inhibitors Of Pfkfb3 And Glycolytic Flux And Their Methods Of Use As Anti-Cancer Therapeutics

US Patent:
2013005, Mar 7, 2013
Filed:
Feb 22, 2011
Appl. No.:
13/580558
Inventors:
Pooran Chand - Birmingham AL, US
Jason A. Chesney - Louisville KY, US
Brian F. Clem - Louisville KY, US
Gilles H. Tapolsky - Louisville KY, US
Sucheta Telang - Louisville KY, US
John O. Trent - Louisville KY, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
ADVANCED CANCER THERAPEUTICS, LLC - Louisville KY
International Classification:
A61K 31/404, C07D 401/06, C12N 5/071, C07D 471/04, A61K 31/4745, A61P 35/00, C07D 209/60, A61K 31/4439
US Classification:
514292, 548427, 514411, 5462767, 514339, 546 84, 546 86, 435375
Abstract:
Small molecule inhibitors of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) having the following formula: Formula (1) are provided herein. Also provided herein are pharmaceutical compositions containing Formula I compounds, together with methods of treating cancer, methods of inhibiting PFK.FB3 enzymatic activity, methods of inhibiting glycolytic flux, and methods of treating tumors by administering an effective amount of a Formula I compound.


Sucheta Telang Photo 4

Pfkfb4 Inhibitors And Methods Of Using The Same

US Patent:
8283332, Oct 9, 2012
Filed:
Apr 16, 2010
Appl. No.:
12/761773
Inventors:
Sucheta Telang - Louisville KY, US
Jason Chesney - Louisville KY, US
Assignee:
University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
A61K 48/00
US Classification:
514 44R
Abstract:
Methods of reducing expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) and methods of treating a cancer in a cell are provided, the methods including contacting a cell with an effective amount of a PFKFB4 inhibitor. Short hairpin RNA (shRNA) and small interfering RNA (siRNA) inhibitors of PFKFB4 and their methods of use are also provided.


Sucheta Telang Photo 5

Family Of Pfkfb3 Inhibitors With Anti-Neoplastic Activities

US Patent:
8557823, Oct 15, 2013
Filed:
Nov 30, 2011
Appl. No.:
13/307552
Inventors:
Gilles Tapolsky - Louisville KY, US
Pooran Chand - Birmingham AL, US
John O. Trent - Louisville KY, US
Sucheta Telang - Louisville KY, US
Brian F. Clem - Louisville KY, US
Jason A. Chesney - Louisville KY, US
Assignee:
Advanced Cancer Therapeutics, LLC - Louisville KY
University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
A01N 43/42, A61K 31/47, A61K 31/497, C07D 215/12, C07D 215/14
US Classification:
51425308, 514311, 514314, 546174
Abstract:
A methods and compounds for inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) are described. Also described are methods of inhibiting cell proliferation, treating cancer, and screening compounds to determine their ability to inhibit PFKFB3.


Sucheta Telang Photo 6

Family Of Pfkfb3 Inhibitors With Anti-Neoplastic Activities

US Patent:
2009007, Mar 19, 2009
Filed:
Jun 18, 2008
Appl. No.:
12/141751
Inventors:
Jason Chesney - Louisville KY, US
John O. Trent - Louisville KY, US
Sucheta Telang - Louisville KY, US
Brian Clem - Louisville KY, US
Jason Meier - Louisville KY, US
International Classification:
A61K 33/24, C12N 9/99, C12N 5/08, A61K 31/444, A61P 35/00, C12Q 1/42, A61K 31/4709, A61K 31/44
US Classification:
424649, 435184, 435375, 435377, 514332, 514355, 514314, 435 21
Abstract:
A methods and compounds for inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) are described. Also described are methods of inhibiting cell proliferation, treating cancer, and screening compounds to determine their ability to inhibit PFKFB3.


Sucheta Telang Photo 7

Small Molecule Choline Kinase Inhibitors, Screening Assays, And Methods For Safe And Effective Treatment Of Neoplastic Disorders

US Patent:
2011021, Sep 1, 2011
Filed:
Jun 28, 2010
Appl. No.:
12/824680
Inventors:
BRIAN CLEM - LOUISVILLE KY, US
SUCHETA TELANG - LOUISVILLE KY, US
JOHN TRENT - LOUISVILLE KY, US
JASON CHESNEY - LOUISVILLE KY, US
POORAN CHAND - BIRMINGHAM AL, US
GILLES TAPOLSKY - LOUISVILLE KY, US
International Classification:
A61K 31/4709, A61K 31/426, A61K 31/428, A61K 31/427, A61K 31/4196, A61K 31/4166, A61K 31/216, A61K 31/24, A61K 31/165, C07D 401/04, C07D 401/12, C07D 417/12, C07D 277/24, C07D 249/12, C07D 233/78, C07C 323/62, C07C 69/736, C07C 235/34, A61P 35/00, G06G 7/58
US Classification:
514314, 514365, 514367, 514371, 514384, 514389, 514391, 514510, 514534, 514543, 514622, 546167, 546171, 548178, 548195, 548204, 5482644, 5483167, 560 9, 560 61, 564182, 703 11
Abstract:
Small molecule choline kinase inhibitors, pharmaceutical compositions thereof, and screening methods for identifying and evaluating choline kinase inhibitors are provided. Safe and effective methods for treating subjects suffering from a disorder or disease characterized by neoplastic cell proliferation employing the choline kinase inhibitors are also provided.